Nottingham, United Kingdom

Geraint Jones

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Geraint Jones: Innovator in Neurological and Psychiatric Treatments

Introduction

Geraint Jones is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating neurological and psychiatric disorders. With a total of seven patents to his name, Jones has established himself as a key figure in medical innovation.

Latest Patents

Among his latest patents are the Oxexin 1 receptor antagonists, which involve novel compounds designed to treat, prevent, ameliorate, control, or reduce the risk of neurological or psychiatric disorders associated with orexin receptors. Additionally, he has developed aminothiazole compounds as inhibitors of CTPS1, showcasing his expertise in creating effective pharmaceutical solutions.

Career Highlights

Throughout his career, Geraint Jones has worked with several prominent companies, including Topivert Pharma Limited and Respivert Limited. His work in these organizations has allowed him to focus on innovative treatments that address critical health issues.

Collaborations

Jones has collaborated with notable professionals in his field, including Thomas Matthew Baker and Matthew Colin Thor Fyfe. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Geraint Jones is a distinguished inventor whose work has the potential to significantly impact the treatment of neurological and psychiatric disorders. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…